We are international
Donate
• health professionals TEXT SIZE   
clinical trials    back

ASH 2011: Dr. Popat - An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy
Rakesh Popat, MD
UCL Cancer Institute
London, United Kingdom
12.07.11

Be the first to comment

 related articles